Newbury Ventures
VC Fund
Menlo Park, United States
Newbury Ventures is a collegial partnership based in Silicon Valley with roots from across the globe, most notably the US, Canada, Europe and the Middle East. We fund exceptional entrepreneurs, and help carry the founders' vision from creation to realization. Since the early 80s, we have financed 150+ successful ventures that grew to generate in excess of $180 billion in combined shareholders’ value. We deploy early stage capital across diversified market sectors and evolve our strategic focus in a constant dialog with the market. We invest in industry verticals, but take an interdisciplinary view of a company's ultimate potential. We seek to team with visionary companies breaking barriers and creating new markets, especially those leveraging advancements in cloud computing, big data, mobile, and social media. We are stage agnostic, but single-mindedly focused on character, commitments and results.
- Total investments:
- 29
- Last investment:
- Lead investor:
- 31%
- Fund size:
- $250M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Newbury Ventures invests in
Stages Newbury Ventures invests in
Countries Newbury Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $2.7M–$22M
- Series B
- $5M–$18M
- Series C
- $8M–$54M
Investment Focus
Industry
- Software 9 (31%)
- Enterprise Software 9 (31%)
- Internet 4 (14%)
- Semiconductor 4 (14%)
- Information Technology 4 (14%)
Stage
- Series B 9 (31%)
- Series A 5 (17%)
- Series C 5 (17%)
- Funding Round 4 (14%)
- Seed 2 (7%)
Country
- United States 17 (59%)
- Canada 3 (10%)
- France 1 (3%)
- Israel 1 (3%)
- Switzerland 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Conrad Lewis
Venture Partners
|
Venture Partners | Total investments: 0 | Find email | |
Ossama Hassanein
Senior Managing Director
|
Senior Managing Director | Total investments: 2 | Find email | |
Tamer Hassanein
Partner
|
Partner | Total investments: 3 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Twenty20 provides a modern, real-world alternative to traditional stock photography. | $22.3M / Series A / Jun 18, 2018 | ||
| From paid search and web analytics, to social media and emerging new tech, AdStage unleashes the power of data to help marketers make decisions that drive business growth. Today, paid marketers at leading agencies and companies in almost every industry depend on our platform as their trusted source of truth. | $6.3M / Series A / Aug 13, 2014 | ||
| Parlio is a social network that connects global citizens to share and discuss perspectives on various subjects. It was founded in 2014 and is based in Palo Alto, California. | $1.7M / Seed / Jun 15, 2014 | ||
| Quanergy Solutions, Inc. is a Silicon Valley-based technology company developing 3D-LiDAR sensors and smart sensing solutions. Quanergy’s mission is to enhance people’s experiences and safety by enabling a new generation of automation processes in the physical security, industrial automation, and smart spaces markets. Quanergy’s industryprice/performance smart LiDAR solutions are deployed by nearly 400 customers and over 50 partners across the globe. It was founded in 2012 and is headquartered in San Jose, CA, USA. | $4.5M / Seed / May 16, 2014 | ||
| NextBio is privately owned software company that provides a platform for life science researchers to search, discover, and share knowledge across public and proprietary data.Nextbio was co-founded by Saeid Akhtari, Ilya Kupershmidt and Mostafa Ronaghi in 2004 and based in Cupertino California, USA.The NextBio Platform is an ontology-basedsemantic framework that connects highly heterogeneous data and textual information. The semantic framework is based on gene, tissue, disease and compound ontologies. This framework contains information from diverse organisms, platforms, data types and research areas is integrated into and correlated within a single searchable environment using proprietary algorithms. It provides a unified interface for researchers to formulate and test new hypotheses across vast collections of experimental data. The enterprise version of the NextBio platform is being used in life science R&D and drug development by researchers and clinicians at: Merck Pharmaceutical, Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Celgene, Genzyme, Eli Lilly and Company, and [[Regeneron Pharmaceuticals. This enterprise version allows internal, proprietary data to be uploaded and integrated into the NextBio database of publicly-available data. Scientists are using NextBio to improve their ability to identify relevant prognostic and predictive molecular signatures which are significant in their research.NextBio was a receiver of the Frost & Sullivan North American Life Sciences Customer Value Enhancement Award in 2008. Since the release it has had more than 1,500,000 visitors. | $8M / Series C / Sep 18, 2009 | ||
| BDNA transforms enterprise asset data by enriching it with market context to vastly simplify integrations, accelerate business transformation and improve decision-making. Leveraging Technopedia®, the most trusted and comprehensive hardware and software asset information source, BDNA leverages automation, a team of content experts and a provenquality framework to reconcile and normalize enterprise asset data to improve all processes and projects.Technopedia’s content library categorizes more than 2 million products from 34,000 suppliers with 2,500 daily updates, providing business-critical information such as compatibility, support dates, end-of life, migration data, current manufacturer and version, and much more. Eliminating manual processes and bottlenecks, BDNA delivers automated and scalable solutions, improving visibility, compliance and time to market.Based in Mountain View, Calif., BDNA operates globally with customers across all segments and markets. For more information, please visit www.bdna.com. | $20M / Series D / Oct 31, 2007 | ||
| NextBio is privately owned software company that provides a platform for life science researchers to search, discover, and share knowledge across public and proprietary data.Nextbio was co-founded by Saeid Akhtari, Ilya Kupershmidt and Mostafa Ronaghi in 2004 and based in Cupertino California, USA.The NextBio Platform is an ontology-basedsemantic framework that connects highly heterogeneous data and textual information. The semantic framework is based on gene, tissue, disease and compound ontologies. This framework contains information from diverse organisms, platforms, data types and research areas is integrated into and correlated within a single searchable environment using proprietary algorithms. It provides a unified interface for researchers to formulate and test new hypotheses across vast collections of experimental data. The enterprise version of the NextBio platform is being used in life science R&D and drug development by researchers and clinicians at: Merck Pharmaceutical, Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Celgene, Genzyme, Eli Lilly and Company, and [[Regeneron Pharmaceuticals. This enterprise version allows internal, proprietary data to be uploaded and integrated into the NextBio database of publicly-available data. Scientists are using NextBio to improve their ability to identify relevant prognostic and predictive molecular signatures which are significant in their research.NextBio was a receiver of the Frost & Sullivan North American Life Sciences Customer Value Enhancement Award in 2008. Since the release it has had more than 1,500,000 visitors. | $7M / Series B / Jun 06, 2007 | ||
| Andigilog, Inc., a fabless analog and mixed-signal semiconductor company, provides intelligent thermal management solutions. Its products include sensor interface integrated circuits, temperature sensors, system controllers, and brushless DC fan motor controllers. The company’s products are used in personal computers, servers, cell phones, andconsumer electronics, as well as in automotive, industrial, biomedical, and security systems. It serves customers in the computing, cellular, consumer, and industrial electronics markets. The company offers its products through a sales network. Andigilog, Inc. was founded in 1996 and is headquartered in Tempe, Arizona. | $18M / Series B / Feb 20, 2007 | ||
| HydroCision develops, manufactures, and markets fluidjet based surgical tools for minimally invasive spine surgery requirements. Its products include SpineJet HydroSurgery System that is used to ablate, cut, and remove targeted tissue for spinal procedures, Spinejet, water-based technology solutions for minimally invasive spine surgeryrequirements, SpineJet HydroDiscectomy Systems, which are used to remove tissue without the risk of thermal energy for minimally invasive discectomy procedures, and AlloJet, systems to prepare bone allografts. The company also provides customer care services. HydroCision, Inc. was formerly known as Surgijet Corporation and changed its name to HydroCision, Inc. in November 1996. The company was founded in 1994 and is headquartered in North Billerica, Massachusetts. | $12.7M / Series G / Jan 09, 2007 | ||
| Spotwave provides carrier-approved, indoor wireless coverage solutions; giving you reliable, "always-on" wireless coverage indoors. They offer wireless carriers and enterprise customers a simple, affordable, effective way to ensure wireless devices have great coverage indoors, where they are used the most. The benefits of Spotwave'sproducts for both their enterprise and business customers, and for carriers are clear. | $10M / Jan 17, 2006 | ||
| See all 29 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Newbury Ventures invest in?
Newbury Ventures invests primarily in Software, Enterprise Software and Internet startups, most often at Series B and Series A stage. Most of the 29 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Newbury Ventures invest in?
Newbury Ventures typically joins rounds of $2.7M–$22M at Series A, $5M–$18M at Series B and $8M–$54M at Series C. These are whole funding-round sizes, not Newbury Ventures's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Newbury Ventures took part in.
How do I contact Newbury Ventures?
Public channels for Newbury Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Newbury Ventures?
The team at Newbury Ventures includes Conrad Lewis (Venture Partners), Ossama Hassanein (Senior Managing Director) and Tamer Hassanein (Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Nov 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
